Literature DB >> 19830218

Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report.

Antonio Di Biagio, Raffaella Rosso, Patrizia Monteforte, Rodolfo Russo, Guido Rovetta, Claudio Viscoli.   

Abstract

INTRODUCTION: Tenofovir disoproxil fumarate (Viread((R))) is the only nucleotide reverse transcriptase inhibitor currently approved for the treatment of HIV. It is frequently prescribed not only for its efficacy but also for its decreased side effect profile compared with other nucleotide analogs. In addition, it is now increasingly recognized as a cause of acquired Fanconi's syndrome in individuals with HIV. CASE
PRESENTATION: We describe a 48-year-old woman infected with HIV, with chronic renal insufficiency, who developed Fanconi's syndrome after inclusion of tenofovir disoproxil fumarate in her antiretroviral therapy. A whole body bone scintigraphy was performed, revealing an abnormal distribution of radiotracer uptake, with characteristic changes compatible with osteomalacia. All symptoms disappeared after tenofovir discontinuation and mineral supplementation. No other explanation for the sudden and complete resolution of the bone disease was found.
CONCLUSION: The case highlights the role of whole body bone scintigraphy in the diagnosis of tenofovir-related osteomalacia.

Entities:  

Year:  2009        PMID: 19830218      PMCID: PMC2737799          DOI: 10.4076/1752-1947-3-8136

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

1.  Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Authors:  David Verhelst; Matthieu Monge; Jean-Luc Meynard; Bruno Fouqueray; Béatrice Mougenot; Pierre-Marie Girard; Pierre Ronco; Jerome Rossert
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

2.  The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.

Authors:  M J Parsonage; E G L Wilkins; N Snowden; B G Issa; M W Savage
Journal:  HIV Med       Date:  2005-09       Impact factor: 3.180

3.  [Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir].

Authors:  M V Torres Isidro; T García Benayas; M del Val Gómez Martínez; F González Gallardo; N Gambí Pisonero; S Castilla Miguel; J González-Lahoz; D Gallego Sanz
Journal:  Rev Esp Med Nucl       Date:  2006 Mar-Apr

Review 4.  Bone disease and HIV infection.

Authors:  Valerianna Amorosa; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2005-11-30       Impact factor: 9.079

5.  Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.

Authors:  Alexandre Karras; Matthieu Lafaurie; André Furco; Anne Bourgarit; Dominique Droz; Daniel Sereni; Christophe Legendre; Frank Martinez; Jean-Michel Molina
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

6.  The role of bone scanning in osteomalacia.

Authors:  I Fogelman; J H McKillop; R G Bessent; I T Boyle; J G Turner; W R Greig
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

7.  Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

Authors:  Robert T Schooley; Peter Ruane; Robert A Myers; Gildon Beall; Harry Lampiris; Daniel Berger; Shan-Shan Chen; Michael D Miller; Erica Isaacson; Andrew K Cheng
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

Review 8.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

9.  Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.

Authors:  B Schaaf; S P Aries; E Kramme; J Steinhoff; K Dalhoff
Journal:  Clin Infect Dis       Date:  2003-07-22       Impact factor: 9.079

Review 10.  Fanconi's syndrome in HIV+ adults: report of three cases and literature review.

Authors:  Karen E Earle; Tara Seneviratne; Joseph Shaker; Dolores Shoback
Journal:  J Bone Miner Res       Date:  2004-05       Impact factor: 6.741

  10 in total
  7 in total

Review 1.  Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Authors:  Jérôme Tourret; Gilbert Deray; Corinne Isnard-Bagnis
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

2.  Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.

Authors:  Lourdes Mateo; Susana Holgado; Maria Luisa Mariñoso; Ricard Pérez-Andrés; Anna Bonjoch; Joan Romeu; Alejandro Olivé
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

3.  Recent developments in HIV-related kidney disease.

Authors:  Michelle M Estrella; Derek M Fine; Mohamed G Atta
Journal:  HIV Ther       Date:  2010-09

4.  Aging, human immunodeficiency virus, and bone health.

Authors:  Kim C Mansky
Journal:  Clin Interv Aging       Date:  2010-09-23       Impact factor: 4.458

5.  Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.

Authors:  Giuseppe Vittorio L De Socio; Gianluigi Fabbriciani; Marco Massarotti; Salvatore Messina; Enisia Cecchini; Bianca Marasini
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-04       Impact factor: 2.576

6.  Tenofovir-associated bone density loss.

Authors:  Iwen F Grigsby; Lan Pham; Louis M Mansky; Raj Gopalakrishnan; Kim C Mansky
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

Review 7.  Bone health and HIV in resource-limited settings: a scoping review.

Authors:  Flavia Kiweewa Matovu; Lalita Wattanachanya; Mags Beksinska; John M Pettifor; Kiat Ruxrungtham
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.